WBCPI 100.32 0.0% CBA 150.23 1.0765% BHP 39.52 1.2295% RIO 119.96 0.9934% CSL 252.92 -1.5109% WBC 31.44 1.1583% NAB 33.98 0.6815% ANZ 29.44 2.9731% WES 72.06 0.6846% MQG 205.63 0.4543% NEM 75.14 1.1169% GMG 31.61 1.0227% XYZ 97.55 -1.7425% RMD 35.4 0.0283% FMG 16.21 0.7458% TLS 4.15 0.2415% WDS 23.25 0.3453% ALL 67.51 0.089% TCL 13.22 2.0062% WOW 29.39 1.6955%
Last update at 2025-03-26T04:59:00Z
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Income before tax | -13.72500M | -12.12400M | -15.04600M | -14.76800M | -8.67500M |
| Minority interest | - | - | - | - | - |
| Net income | -13.72500M | -12.12400M | -15.04600M | -14.76800M | -8.68100M |
| Selling general administrative | 16.11M | 11.95M | 13.11M | 7.51M | 3.62M |
| Selling and marketing expenses | 4.00M | 3.07M | 2.47M | 3.48M | 3.04M |
| Gross profit | 12.62M | 9.29M | 5.29M | 2.81M | 0.46M |
| Reconciled depreciation | 2.68M | 2.75M | 2.01M | 0.85M | 0.05M |
| Ebit | -13.12000M | -12.06300M | -15.04400M | -14.06400M | -8.66900M |
| Ebitda | -10.43700M | -9.31600M | -13.03000M | -13.21600M | -8.62100M |
| Depreciation and amortization | 2.68M | 2.75M | 2.01M | 0.85M | 0.05M |
| Non operating income net other | - | - | - | - | - |
| Operating income | -13.32400M | -12.32100M | -14.92900M | -11.91600M | -8.66900M |
| Other operating expenses | 13.64M | 10.78M | 14.84M | 15.02M | 9.24M |
| Interest expense | 0.60M | 0.06M | 0.00200M | 0.70M | 0.00600M |
| Tax provision | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Interest income | 0.81M | 0.00500M | 0.18M | 0.70M | 0.21M |
| Net interest income | -0.77200M | -0.29800M | -0.17700M | -0.70400M | 0.20M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 1.25M | 1.00M | 0.53M | -0.82000M | 0.00600M |
| Total revenue | 24.82M | 20.08M | 11.07M | 4.97M | 0.77M |
| Total operating expenses | 26.21M | 22.06M | 20.68M | 15.57M | 8.93M |
| Cost of revenue | 12.20M | 10.78M | 5.78M | 2.16M | 0.31M |
| Total other income expense net | 0.64M | 0.94M | 0.53M | -1.52400M | -0.00600M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -13.72500M | -12.12400M | -15.04600M | -14.76800M | -8.67500M |
| Net income applicable to common shares | -13.72500M | -12.12400M | -15.04600M | -14.76800M | -8.67500M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
| Total assets | 23.65M | 48.34M | 56.56M | 53.91M | 54.28M |
| Intangible assets | - | 0.90M | 1.58M | 2.20M | 2.19M |
| Earning assets | - | - | - | - | - |
| Other current assets | 1.71M | 1.51M | 1.45M | 0.60M | 1.62M |
| Total liab | 23.34M | 18.57M | 15.12M | 11.22M | 6.26M |
| Total stockholder equity | 0.31M | 29.77M | 41.45M | 42.70M | 48.02M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 2.48M | 1.68M | 0.64M | 0.76M | 0.07M |
| Common stock | 86.33M | 85.34M | 82.04M | 68.05M | 54.40M |
| Capital stock | - | 85.34M | 82.04M | 68.05M | 54.40M |
| Retained earnings | -88.74400M | -56.75100M | -43.47700M | -40.12000M | -25.31400M |
| Other liab | - | 0.86M | 0.34M | 0.46M | 0.21M |
| Good will | - | 17.74M | 17.74M | 17.74M | 19.63M |
| Other assets | - | 0.42M | 0.33M | 0.35M | 0.28M |
| Cash | 0.33M | 3.87M | 6.21M | 6.39M | 10.14M |
| Cash and equivalents | - | - | - | - | 10.14M |
| Total current liabilities | 16.90M | 16.92M | 9.77M | 6.76M | 3.51M |
| Current deferred revenue | 1.66M | 3.68M | 3.59M | 2.72M | 1.51M |
| Net debt | 6.21M | 0.98M | -1.06800M | -2.33900M | -7.42200M |
| Short term debt | 1.30M | 4.07M | 0.14M | 0.05M | 0.18M |
| Short long term debt | - | 3.88M | - | - | - |
| Short long term debt total | 6.54M | 4.85M | 5.14M | 4.05M | 2.72M |
| Other stockholder equity | - | -28.58900M | -38.56700M | -27.92600M | -29.08900M |
| Property plant equipment | - | 13.57M | 19.15M | 18.74M | 16.79M |
| Total current assets | 10.89M | 15.72M | 17.78M | 14.88M | 15.38M |
| Long term investments | - | 0.42M | 0.33M | 0.35M | 0.28M |
| Net tangible assets | - | 11.13M | 22.14M | 22.76M | 26.20M |
| Short term investments | - | - | - | - | - |
| Net receivables | 4.86M | 4.13M | 6.30M | 2.68M | 1.39M |
| Long term debt | - | - | - | - | 2.54M |
| Inventory | 3.98M | 6.20M | 3.82M | 5.21M | 2.23M |
| Accounts payable | 11.46M | 7.50M | 5.41M | 3.23M | 1.74M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 2.73M | 1.18M | 2.88M | 14.77M | 18.93M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | 54.40M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 1.22M | -32.20700M | -38.46300M | -38.67900M | -36.71600M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 12.76M | 32.62M | 38.79M | 39.03M | 38.90M |
| Capital lease obligations | - | 0.97M | 5.14M | 4.05M | 0.18M |
| Long term debt total | - | 0.79M | 5.00M | 4.00M | 2.54M |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Investments | -1.48700M | -0.98200M | -2.40300M | -14.13900M | 0.20M |
| Change to liabilities | 3.70M | 2.90M | 3.15M | 1.78M | 1.01M |
| Total cashflows from investing activities | -1.48700M | -0.98200M | -2.40300M | -14.13900M | -1.67100M |
| Net borrowings | 3.69M | -0.16400M | -0.02300M | -3.42700M | -3.42700M |
| Total cash from financing activities | 5.55M | 9.89M | 9.18M | 23.77M | 20.49M |
| Change to operating activities | -0.02000M | -0.92700M | 1.38M | -1.08100M | 0.54M |
| Net income | -13.72500M | -12.12400M | -15.04600M | -14.76800M | -8.67500M |
| Change in cash | -2.33100M | -0.18300M | -3.75500M | -4.77500M | 12.62M |
| Begin period cash flow | 6.21M | 6.39M | 10.14M | 14.92M | 2.30M |
| End period cash flow | 3.87M | 6.21M | 6.39M | 10.14M | 14.92M |
| Total cash from operating activities | -6.29400M | -9.05400M | -10.44500M | -14.23800M | -6.15600M |
| Issuance of capital stock | 1.95M | 10.04M | 9.27M | 28.67M | 20.73M |
| Depreciation | 2.06M | 2.09M | 1.42M | 0.49M | 0.05M |
| Other cashflows from investing activities | - | - | 0.00000M | -2.45700M | 0.20M |
| Dividends paid | - | 0.00600M | 0.01M | - | - |
| Change to inventory | -2.38200M | 1.39M | -2.98200M | -1.60100M | -0.54600M |
| Change to account receivables | 2.18M | -3.62200M | -1.29500M | -0.92000M | -0.43900M |
| Sale purchase of stock | 1.95M | -0.01300M | -0.01300M | 28.67M | 20.73M |
| Other cashflows from financing activities | 3.69M | -0.11200M | -0.02300M | -0.11200M | -1.67100M |
| Change to netincome | 1.28M | 0.58M | 2.33M | 1.50M | 1.91M |
| Capital expenditures | 1.49M | 0.98M | 2.40M | 11.68M | 1.87M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -0.20600M | -2.22800M | -4.27700M | -2.52100M | 0.21M |
| Stock based compensation | 1.16M | 1.01M | 2.52M | -0.49300M | - |
| Other non cash items | 5.37M | 0.98M | 3.18M | 0.04M | 8.63M |
| Free cash flow | -7.78100M | -10.03600M | -12.84800M | -25.92000M | -8.02700M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
| Company | Change (AUD) | Price (AUD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AGH Althea Group Holdings Ltd |
-0.001 4.35% | 0.02 | - | - | 0.41 | 34.39 | 0.76 | -1.8035 |
| AFP AFT Pharmaceuticals Ltd |
- -% | 2.30 | 23.00 | 11.44 | 1.22 | 3.15 | 1.46 | 12.67 |
| LV1 Live Verdure Ltd |
- -% | 0.81 | 3.05 | - | 1.59 | 1.29 | 68.85 | 1.86 |
| SNT Syntara Limited |
-0.002 2.63% | 0.07 | - | 20.45 | 16.32 | 6.85 | 6.32 | -2.1607 |
| VLS Vita Life Sciences Ltd |
- -% | 1.95 | 12.06 | - | 1.35 | 2.04 | 0.99 | 5.87 |
Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland. It also offers education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private medical cannabis clinic network under the MyAccess Clinics name. Althea Group Holdings Limited was founded in 2016 and is based in Melbourne, Australia.
Suite 2, 360 Elizabeth Street, Melbourne, VIC, Australia, 3000
| Name | Title | Year Born |
|---|---|---|
| Mr. Joshua Michael Fegan | CEO, MD & Exec. Director | NA |
| Mr. Robert Meissner | CFO & Company Sec. | NA |
| Mr. David Sauer | Gen. Counsel | NA |
| Mr. Joshua Michael Fegan | CEO, MD & Executive Director | NA |
| Mr. Robert Meissner | CFO & Company Secretary | NA |
| Mr. David Sauer | General Counsel | NA |
| Mr. Joshua Michael Fegan | CEO, MD & Executive Director | NA |
| Mr. Robert Meissner | CFO & Company Secretary | NA |
| Mr. David Sauer | General Counsel | NA |
| Mr. Joshua Michael Fegan | CEO, MD & Executive Director | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
NZ
AU
UK
CA
US
Please wait processing your request...